Loading...

Becton, Dickinson and Company

BDXANYSE
Healthcare
Medical - Instruments & Supplies
$59.24
$-1.36(-2.24%)

Becton, Dickinson and Company BDXA Peers

See (BDXA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BDXA$59.24-2.24%49.5B21.44$2.76+2.40%
ISRG$543.01+4.10%191.5B78.24$6.83N/A
BDX$171.77+0.51%48.7B32.94$5.16+2.40%
ALC$88.27+0.80%43.1B38.72$2.25+0.38%
RMD$255.48-0.94%37.6B28.76$8.91+0.83%
WST$219.13-0.86%15.7B34.44$6.36+0.38%
BAX$30.47-0.47%15.7B-58.67-$0.52+2.63%
HOLX$65.60+2.06%14.5B27.36$2.38N/A
COO$71.43+2.72%13.9B33.67$2.07N/A
BDXB$48.16+1.39%13.7B7.60$6.33+2.40%
Showing 1 to 10 of 75 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BDXA vs ISRG Comparison

BDXA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BDXA stands at 49.5B. In comparison, ISRG has a market cap of 191.5B. Regarding current trading prices, BDXA is priced at $59.24, while ISRG trades at $543.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BDXA currently has a P/E ratio of 21.44, whereas ISRG's P/E ratio is 78.24. In terms of profitability, BDXA's ROE is +0.06%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, BDXA is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for BDXA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;